TABLE 1.
Baseline characteristics of the cohort studies included1
| Enrollment year, study, and sex | Follow-up period2 | Baseline cohort size | Age range at entry | Total energy intake3 | No. of all deaths | No. of cancer deaths | No. of CVD deaths |
| y | kcal/d | ||||||
| 1990–1992 | |||||||
| JPHC1 (males) | 14.2 ± 3.7 | 20,595 | 40–59 | 2124 (879) | 2300 | 953 | 600 |
| JPHC1 (females) | 14.7 ± 3.1 | 22,443 | 40–59 | 1398 (440) | 1128 | 541 | 284 |
| 1992–1995 | |||||||
| JPHC2 (males) | 11.2 ± 3.2 | 26,721 | 40–69 | 1675 (684) | 3662 | 1621 | 882 |
| JPHC2 (females) | 11.7 ± 2.6 | 29,690 | 40–69 | 1087 (330) | 1805 | 784 | 478 |
| 1990 | |||||||
| Miyagi (males) | 12.6 ± 2.7 | 21,536 | 40–64 | 1885 (886) | 2335 | 838 | 424 |
| Miyagi (females) | 12.9 ± 2.3 | 23,430 | 40–64 | 1307 (438) | 1152 | 421 | 202 |
| 1995 | |||||||
| Ohsaki (males) | 9.8 ± 3.8 | 23,462 | 40–80 | 1757 (829) | 4605 | 1649 | 1305 |
| Ohsaki (females) | 10.0 ± 3.8 | 25,443 | 40–80 | 1266 (461) | 2606 | 769 | 919 |
| 2000–2002 | |||||||
| HEALS (males) | 6.6 ± 1.1 | 4884 | 20–75 | 2806 (967) | 284 | 45 | 130 |
| HEALS (females) | 6.6 ± 0.8 | 6512 | 17–61 | 2431 (850) | 107 | 14 | 41 |
| 1992–1993 | |||||||
| Seoul (males) | 14.7 ± 1.7 | 13,600 | 25–82 | 2397 (497) | 808 | 424 | 145 |
| 1996–2000 | |||||||
| SWHS (females) | 8.6 ± 1.2 | 74,933 | 40–71 | 1634 (496) | 2908 | 1346 | 804 |
| 1990–1992 | |||||||
| CVDFACTS (males) | 14.9 ± 3.6 | 1512 | 18–92 | 2325 (943) | 332 | 80 | 93 |
| CVDFACTS (females) | 15.6 ± 2.7 | 1960 | 18–87 | 1716 (667) | 251 | 73 | 66 |
| Total | 24,283 | 9558 | 6373 |
1
CVD, cardiovascular disease; CVDFACTS, Cardiovascular Diseases Risk Factor Two-Township Study; HEALS, Health Effects of Arsenic Longitudinal Study; JPHC, Japan Public Health Center-Based Prospective Study; Miyagi, Miyagi Cohort Study; Ohsaki, Ohsaki National Health Insurance Cohort Study; Seoul, Seoul Male Cohort Study; SWHS, Shanghai Women's Health Study.
2
All values are means ± SDs.
3
All values are medians; IQRs in parentheses.